Stocks Overview

LAST PRICE
11.6700
TODAY'S CHANGE (%)
Trending Down-0.3700 (-3.0731%)

Bid / Lots
11.5100/ 5
Ask / Lots
11.9700/ 5
Open / Previous Close
12.0400 / 12.0400
Day Range
Low 11.2700
High 12.1400
52 Week Range
Low 2.5700
High 13.8500
Volume
941,984
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Monday's close: 12.04
Time	Volume	CRMD
09:32 ET	21958	12.0137
09:33 ET	7205	11.8745
09:35 ET	2622	12
09:37 ET	5950	11.98
09:39 ET	6600	11.9612
09:42 ET	416	12.005
09:44 ET	2568	12.001
09:46 ET	9431	11.88
09:48 ET	1500	11.91
09:50 ET	6651	12.0099
09:51 ET	8464	11.95
09:53 ET	100	11.95
09:55 ET	100	11.95
09:57 ET	11131	11.875
10:00 ET	440	11.8571
10:02 ET	718	11.85
10:04 ET	9275	11.8175
10:06 ET	10844	11.78
10:08 ET	2227	11.775
10:09 ET	1095	11.7965
10:11 ET	6266	11.7342
10:13 ET	4642	11.71
10:15 ET	11382	11.715
10:18 ET	12636	11.75
10:20 ET	2729	11.705
10:22 ET	2126	11.715
10:24 ET	15257	11.63
10:26 ET	13397	11.63
10:27 ET	4852	11.6403
10:29 ET	46972	11.585
10:31 ET	1016	11.564
10:33 ET	2889	11.5599
10:36 ET	20563	11.485
10:38 ET	17241	11.355
10:40 ET	7409	11.37
10:42 ET	13882	11.39
10:44 ET	1400	11.385
10:45 ET	5902	11.36
10:47 ET	1980	11.4
10:49 ET	10085	11.4
10:51 ET	4300	11.44
10:54 ET	12315	11.4
10:56 ET	2956	11.37
10:58 ET	1801	11.3503
11:00 ET	4159	11.3265
11:02 ET	12743	11.3
11:03 ET	13055	11.35
11:05 ET	1396	11.37
11:07 ET	3500	11.34
11:09 ET	1000	11.32
11:12 ET	7953	11.39
11:14 ET	3195	11.4434
11:16 ET	700	11.41
11:18 ET	3402	11.4
11:20 ET	5500	11.415
11:21 ET	5400	11.43
11:23 ET	7410	11.44
11:25 ET	923	11.45
11:27 ET	1994	11.4662
11:30 ET	4029	11.52
11:32 ET	9150	11.55
11:34 ET	6420	11.53
11:36 ET	875	11.545
11:38 ET	200	11.55
11:39 ET	3330	11.55
11:41 ET	1110	11.5259
11:43 ET	4380	11.5
11:45 ET	1200	11.5283
11:48 ET	400	11.52
11:50 ET	100	11.4975
11:52 ET	5238	11.45
11:54 ET	370	11.4584
11:56 ET	6760	11.52
11:57 ET	1653	11.51
11:59 ET	523	11.5
12:03 ET	300	11.491
12:06 ET	6502	11.43
12:08 ET	4127	11.46
12:10 ET	3200	11.51
12:12 ET	850	11.528
12:14 ET	300	11.5166
12:15 ET	302	11.515
12:17 ET	858	11.5
12:19 ET	1584	11.5388
12:21 ET	1040	11.5249
12:24 ET	2615	11.485
12:26 ET	2550	11.5
12:28 ET	800	11.5099
12:30 ET	1646	11.525
12:32 ET	1302	11.53
12:35 ET	781	11.51
12:37 ET	1400	11.52
12:42 ET	3012	11.518
12:44 ET	6560	11.52
12:46 ET	1330	11.525
12:48 ET	1401	11.51
12:50 ET	200	11.51
12:51 ET	2363	11.5
12:53 ET	2300	11.52
12:55 ET	2545	11.53
12:57 ET	573	11.53
01:00 ET	350	11.515
01:02 ET	11520	11.41
01:06 ET	300	11.45
01:08 ET	700	11.435
01:09 ET	400	11.445
01:11 ET	200	11.45
01:18 ET	1163	11.45
01:20 ET	710	11.4395
01:22 ET	700	11.43
01:24 ET	3600	11.52
01:26 ET	600	11.53
01:27 ET	117	11.55
01:29 ET	1058	11.57
01:31 ET	200	11.57
01:36 ET	453	11.58
01:38 ET	2800	11.6
01:40 ET	955	11.57
01:42 ET	100	11.57
01:44 ET	1723	11.55
01:45 ET	1153	11.5904
01:47 ET	100	11.58
01:49 ET	100	11.57
01:51 ET	100	11.55
01:56 ET	100	11.56
01:58 ET	200	11.56
02:00 ET	2010	11.56
02:02 ET	100	11.56
02:03 ET	10828	11.61
02:05 ET	2200	11.62
02:07 ET	1148	11.605
02:09 ET	200	11.605
02:12 ET	700	11.57
02:14 ET	723	11.58
02:16 ET	260	11.5794
02:20 ET	400	11.57
02:21 ET	200	11.58
02:23 ET	6851	11.57
02:25 ET	6163	11.57
02:27 ET	1046	11.58
02:30 ET	900	11.59
02:32 ET	513	11.57
02:36 ET	100	11.566
02:39 ET	100	11.57
02:41 ET	100	11.565
02:43 ET	1250	11.555
02:45 ET	2157	11.55
02:48 ET	2719	11.565
02:52 ET	2100	11.56
02:54 ET	4995	11.61
02:56 ET	1000	11.62
02:57 ET	1967	11.62
02:59 ET	714	11.62
03:01 ET	886	11.61
03:03 ET	5301	11.62
03:06 ET	403	11.63
03:08 ET	2800	11.64
03:10 ET	2811	11.66
03:12 ET	900	11.68
03:14 ET	2844	11.67
03:15 ET	887	11.67
03:19 ET	1072	11.6615
03:21 ET	600	11.6634
03:24 ET	11301	11.65
03:26 ET	1520	11.65
03:28 ET	2038	11.64
03:30 ET	1653	11.6703
03:32 ET	890	11.6678
03:33 ET	624	11.66
03:35 ET	2901	11.63
03:39 ET	768	11.63
03:42 ET	6030	11.61
03:44 ET	5424	11.65
03:46 ET	7100	11.685
03:48 ET	700	11.66
03:50 ET	5139	11.6799
03:51 ET	2225	11.695
03:53 ET	4067	11.67
03:55 ET	2080	11.68
03:57 ET	8804	11.69
04:00 ET	97023	11.67

Data delayed at least 15 minutes.

Nov 4, 2024
- CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium, from 8:30AM ET on Monday Nov 04, 2024 by Dow Jones
  8:30AM ET on Monday Nov 04, 2024 by Dow Jones
Oct 31, 2024
- DJ CorMedix Is Maintained at Buy by Needham, from 6:21AM ET on Thursday Oct 31, 2024 by Dow Jones
  6:21AM ET on Thursday Oct 31, 2024 by Dow Jones
Oct 30, 2024
- DJ CorMedix Down Over 15%, On Pace for Largest Percent Decrease Since June 2023 -- Data Talk, from 11:56AM ET on Wednesday Oct 30, 2024 by Dow Jones
  11:56AM ET on Wednesday Oct 30, 2024 by Dow Jones
- *DJ CorMedix 3Q Loss/Shr 5c >CRMD, from 7:30AM ET on Wednesday Oct 30, 2024 by Dow Jones
  7:30AM ET on Wednesday Oct 30, 2024 by Dow Jones
- CorMedix Inc. Reports Third Quarter and Nine Month 2024 Financial Results and Provides Business Update, from 7:30AM ET on Wednesday Oct 30, 2024 by Dow Jones
  7:30AM ET on Wednesday Oct 30, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesCRMD CorMedix Inc	730.6M	-14.6x	---
United StatesZVRA Zevra Therapeutics Inc	471.5M	-5.1x	---
United StatesELTP Elite Pharmaceuticals Inc	577.9M	29.3x	---
United StatesCPLFY Cipla Ltd	14.9B	0.0x	---
United StatesETON Eton Pharmaceuticals Inc	250.9M	-35.3x	---
United StatesIXHL Incannex Healthcare Inc	51.9M	-2.6x	---
As of 2024-11-12

CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter. DefenCath is a formulation of taurolidine 13.5 mg/mL, and heparin 1000 USP Units/mL indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter (CVC). In addition to DefenCath, the Company has sponsored a pre-clinical research collaboration for the use of taurolidine as a possible treatment for rare pediatric tumors.

Contact Information

Headquarters: 300 Connell Drive, Suite 4200BERKELEY HEIGHTS, NJ, United States 07922
Phone: 908-517-9500
Fax: 302-636-5454

Executives

Independent Chairman of the Board: Myron Kaplan
Chief Executive Officer, Director: Joseph Todisco
Chief Financial Officer, Executive Vice President: Matthew David
Executive Vice President, Chief Clinical Strategy and Operations Officer: Elizabeth Massonhurlburt
Executive Vice President, Chief Legal Officer and Corporate Secretary: Beth Kaufman

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$730.6M
Revenue (TTM)	$12.3M
Shares Outstanding	60.7M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	1.60
EPS	$-0.80
Book Value	$1.28
P/E Ratio	-14.6x
Price/Sales (TTM)	59.6
Price/Cash Flow (TTM)	---
Operating Margin	-415.59%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

CorMedix Inc
NASDAQ:CRMDUnited States

Search Criteria

Charts

Recent News

Nov 4, 2024

CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium, from 8:30AM ET on Monday Nov 04, 2024 by Dow Jones

Oct 31, 2024

DJ CorMedix Is Maintained at Buy by Needham, from 6:21AM ET on Thursday Oct 31, 2024 by Dow Jones

Oct 30, 2024

DJ CorMedix Down Over 15%, On Pace for Largest Percent Decrease Since June 2023 -- Data Talk, from 11:56AM ET on Wednesday Oct 30, 2024 by Dow Jones

*DJ CorMedix 3Q Loss/Shr 5c >CRMD, from 7:30AM ET on Wednesday Oct 30, 2024 by Dow Jones

CorMedix Inc. Reports Third Quarter and Nine Month 2024 Financial Results and Provides Business Update, from 7:30AM ET on Wednesday Oct 30, 2024 by Dow Jones

Pharmaceuticals - Generic & Specialty Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar